Abbott India Limited (BOM: 500488)
29,772
-113 (-0.38%)
At close: Sep 10, 2024
Abbott India Company Description
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India.
The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management.
It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products.
The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
Abbott India Limited
Country | India |
Founded | 1910 |
Industry | Pharmaceutical Preparations |
Employees | 3,814 |
CEO | Swati Dalal |
Contact Details
Address: Godrej BKC, Plot C-68 Mumbai, Maharashtra 400051 India | |
Phone | 91 22 5046 1000 |
Website | abbott.co.in |
Stock Details
Ticker Symbol | 500488 |
Exchange | Bombay Stock Exchange |
Fiscal Year | April - March |
Reporting Currency | INR |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Swati Dalal | Chief Executive Officer |
Sridhar Kadangode | Chief Financial Officer |